Review Article
Bioclinical Parameters Driving Decision-Making of Subsequent Lines of Treatment in Metastatic Castration-Resistant Prostate Cancer
Table 1
Patients’ features.
| Clinical trial | Median age | Range | ≥75 years | PS 2 | Visceral metastases |
| TROPIC | 68 | 62–73 | 18% | 7% | 25% | COU-AA-301 | 69 | 42–95 | 28% | 10% | 11% (liver metastases) | AFFIRM | 69 | 41–92 | 25% | 8.5% | 23.2% |
|
|